CLINICAL LAB SCIENEC

INDEX 465
Complete blood count (CBC), 80,
326
Confidentiality
of medical information and records,
69, 69f
standards of, 71–75, 71f, 74f, 75f
access to personal medical
records, 73
communications related to,
74–75, 75f
consumer complaints, 75
HIPAA, 72–73
notice of privacy practices, 73,
74f
personal medical information,
limited and specified use of,
74
prohibition on marketing, 74
stronger state laws, 74
Consent, informed, patient’s rights
for, basics of, 66, 68
Consumer(s), health care, aiding,
160–161
Consumer complaints, confidentiality-related,
75
Contaminated waste materials, disposal
of, 97, 98f
Contamination
by bacteria, 282
barriers against, PPE, 122f–125f,
124–126
chemical, 282, 282f
Continuous quality improvement
(CQI), 233
Contract(s), for services, equipment,
and supplies, costs related to,
medical service costs impacted
by, 167
Control(s)
assayed, defined, 245–246
engineered, 116
defined, 147
infection-related. See Infection
control
out-of-range, steps in correction
of, 247–248
unassayed, defined, 246
work practice, 116, 147
in bloodborne- and airborne
pathogen–related infection
prevention, 150
Control specimens, defined, 235t
Convalescent sample, 127
Conversion factors, from mg/dL to
mmol/L, 212t
Cost per billable test, 165
Cost per reportable test, 165
Cotton fibers, 308f
Coulter Electronics, 327
Coumadin. See Warfarin
(Coumadin)
Covered blood pathogens, 112–113
Covered organisms, 112
CPU (central processing unit), in QA
results, 261–262
CQI. See Continuous quality
improvement (CQI)
C-reactive protein, in serum,
determination of, 407–410
equipment and supplies, 408–490
principles, 407–408
procedure, 409
reporting of results, 409–410
Creatinine, described, 227
Credentialing
of laboratory personnel, 27–59.
See also Medical laboratory
workers, credentialing of
of medical laboratory technical
workers, 17, 18t
of medical laboratory workers,
27–59. See also Medical laboratory
workers, credentialing
of
competition between agencies,
47–50
Credentialing agencies, 47–48
Crick, F., in history of laboratory
medicine, 8
Crimean War, treatment modalities
emerging from, 9
Cross match, 418
CRP. See C-reactive protein
Crystal(s). See also specific types, e.g.,
Calcium oxalate crystals
abnormal, in patients with
metabolic diseases, 307–308,
308f, 309t
normal, in urine samples, 306,
307f, 307t
CSF. See Cerebrospinal fluid (CSF)
Cubital vein, defined, 266
Cumulative summation (CUSUM),
241–242
Cumulative summation (CUSUM)
graph, 236
Custodian(s), infection control in,
122–123
CUSUM, 241–242
CUSUM graph, 236
Cuvette(s), 186, 365
CV. See Coefficient of variation (CV)
Cyanmethemoglobin, in blood,
quantitative determination
of, 345
Cylinder(s), graduated, 189–190,
190f
Cystine crystals, 308f
Cytotechnologists, 29
D
D antigen, 428
Daily glucose tests, normal control
in, graph for, 240–241
Data, spread of, described, 238
Decontamination, in infection control,
153
Degrees Celsius, degrees Fahrenheit
to, conversion of, 214, 214f
formula for, 214, 215t
Degrees Fahrenheit, to degrees Celsius,
conversion of, 214, 214f
formula for, 214, 215t
Deionized water, preparation of,
methodology for, 217
Delta checks, 245
Density, defined, 221
Deoxyribonucleic acid (DNA), 84
Department of Health, Education
and Welfare (HEW). See
Department of Health and
Human Services (HHS)
Department of Health and Human
Services (HHS), 14, 44, 72,
116
Office for Civil Rights of, 75
Diabetic coma, electrolyte imbalances
and, 382
Differential WBC count, 329–331,
330t, 335–339, 336f, 338f
Differential WBC counter, 335, 336f
Dilution(s)
defined, 223
Copyright 2010 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).
Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.